IRCT20210612051548N3尚未招募2 期
The efficiency of endoradiotherapy with 177Lu-Trastuzumab in patients with resistant or relapsed HER2-positive breast cancer
Boushehr University of Medical Sciences0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- Female
入选标准
- •Age =18 years
- •Patients with confirmed HER2-positive breast cancer using 68Ga-Trastuzumab PET/CT
- •Eastern Cooperative Oncology Group Performance Status (ECOG) = 2
- •Having hematologic parameters as: (i) Absolute neutrophil count = 1000 cells/mm3; (ii) Platelet count = 100,000/mm3; (iii) Hemoglobin = 9 g/dL
- •Signed informed consent form
排除标准
- •Pregnant woman
- •Inability to provide written informed consent.
- •Patients with known sensitivity or contraindication to Herceptin.
- •The patient had an active, uncontrolled bacterial, viral, or fungal infection(s) requiring systemic therapy.
- •Patients have psychiatric illness/social situations that would interfere with compliance with study requirements
研究者
相似试验
招募中
1 期
Radioimmunotherapy with 177Lu-DOTA-RITUXIMAB in B-cell lymphomaIRCT20210612051548N4Boushehr University of Medical Sciences10
进行中（未招募）
不适用
Receptorial radiotherapy with 177Lu DOTATATE in somatostatine receptors positive tumours, a phase II study.cancer patientsMedDRA version: 14.1Level: HLGTClassification code 10014713Term: Endocrine neoplasms malignant and unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-002891-18-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI
已完成
1 期
Radionuclide therapy using 177Lu-PSMA: a pilot study in men with castrate-resistant prostate cancer (LuPSMA trial)castrate-resistant prostate cancerACTRN12618001552279St Vincent's Hospital15
进行中（未招募）
不适用
Receptorial radiotherapy with 177Lu-DOTA-Tyr3-Octreotate as Maintaining Therapy in Extended Small Cell Lung Cancer (SCLC) after a first standard chemotherapy line - IRST162.02oncological patientsMedDRA version: 12.1Level: LLTClassification code 10026532Term: Malignant neoplasm of thoraxEUCTR2010-018333-21-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI
已完成
2 期
Endo RF in axillary hydradenitis suppurativaHidradenitis suppurativaIRCT20140624018210N12Iran University of Medical Sciences18